Results 151 to 160 of about 15,762 (228)

Nuclear-Cytoplasmic Axis in Cancer: From Protein Mislocalization to Anticancer Drug Resistance. [PDF]

Oncol Res
Zhu X, He M, Wang L, Su R, Zhong L, Guo T, Wang H, Zou D.   +7 more
europepmc   +1 more source

Exportin 1 Inhibitor Combined With Venetoclax Induces Apoptosis in Myelodysplastic Syndrome by Mitochondria-Induced Apoptosis Pathway. [PDF]

J Clin Lab Anal
Liu X, Huang L, Wang J, Guo Y, Shen H, Zhao X, Yue L, Liu Z, Fu R.   +8 more
europepmc   +1 more source

Drug Resistance in Multiple Myeloma: Tumor-Intrinsic Mechanisms and the Bone Marrow Microenvironment. [PDF]

Cell Biochem Funct
Chen Y, Huang W, Tang M, Wang X.
europepmc   +1 more source

XPO1: From basic research to clinical treatment (Review). [PDF]

Oncol Rep
Yang C, Zhu J, Zheng X, Hou X, Zhao J, Pan Y, Tang Y.   +6 more
europepmc   +1 more source

Karyopherin Dysfunction Is a Key Driver of Aging. [PDF]

Aging Cell
Lapierre LR.
europepmc   +1 more source

Combination effect of Exportin 1 inhibitor (KPT-335) with doxorubicin or vincristine in canine lymphoma cell lines. [PDF]

J Vet Med Sci
Primarizky H, Kambayashi S, Baba K, Tani K, Okuda M.   +4 more
europepmc   +1 more source

Biochemical evaluation of Jihua hemostatic suppository in hemorrhagic internal hemorrhoids: Modulation of XPO1, VEGF, and collagen I/III expression and inflammatory biomarkers. [PDF]

J Med Biochem
Wang C, Kang Y, Wang Y, Liu Y, Shi M, Liu X, Jiao H.   +6 more
europepmc   +1 more source

Multiple roads between the nucleus and the cytoplasm: classes of linear NLSs and NESs and their receptors. [PDF]

Curr Opin Struct Biol
Wing CE, Chook YM.
europepmc   +1 more source

Anticancer effects of an XPO1 inhibitor (selinexor) with sotorasib following omeprazole preconditioning in KRAS G12C-mutant non-small cell lung cancer cells in vitro and in a mouse tumor xenograft. [PDF]

Neoplasia
González J, Cai X, Diao W, Roué G, València-Clua K, Olmo-González D, González-Cao M, Jain A, Jantus-Lewintre E, Giménez-Capitán A, Molina-Vila MA, Codony-Servat J, Cao P, Rosell R.   +13 more
europepmc   +1 more source

<i>KRAS</i> under attack: recent advances in targeted therapies involving G12C inhibitors and XPO1 inhibition. [PDF]

Transl Lung Cancer Res
Falk M, Schatz S, Tiemann M, Ficker JH, Brueckl WM.   +4 more
europepmc   +1 more source